WilmerHale Webinar: IP Migration Strategies for Life Sciences Companies

WilmerHale Webinar: IP Migration Strategies for Life Sciences Companies

Speaking Engagement

An increasing number of life sciences companies of all sizes are considering intellectual property migration as an opportunity to achieve legal, tax and operational efficiencies. When considering the adoption of this strategy, it is critically important for executives to understand the requirements and benefits associated with such a reorganization of an IP portfolio.

During this webinar, WilmerHale Partners Rich Andersen, Steve Barrett and Stuart Falber discuss: the criteria to determine whether a company is a candidate; the advantages and disadvantages of IP migration; the process for companies to reorganize their IP portfolio; and representative structures as they pertain to life sciences companies.

View the Webinar Recording
View the Presentation Materials

Read More About the Event



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.